Pharmacokinetics and Bioequivalence Comparison of 600 mg Single-Dose Linezolid Oral Suspension and Tablet Formulation in Healthy Chinese Subjects
*Corresponding Author:
Copyright: © 2019 . This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
To read the full article Peer-reviewed Article PDF 
Abstract
study heritage: Linezolid is indicated for the treatment of infections resulting from cardio Gram-high-quality bacteria. An oral suspension formula poses an opportunity to strong oral formulations in patients with swallowing difficulties, especially pediatric and geriatric sufferers, or sufferers with feeding tubes
